Orcutt, X., Nimgaonkar, V., Sun, L., Aggarwal, C., Cohen, A. B., Mamtani, R., Long, Q., Parikh, R. B. (2026). Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20523